Author | Udai Banerji, MD | OncLive

Author | Udai Banerji, MD

Articles

Dr. Banerji on the Clinical Activity of VS-6766/Defactinib in KRAS-Mutant Tumors

May 08, 2020

Video

Udai Banerji, MD, discusses the results from a phase 1 trial with the combination of VS-6766 (CH5126766) and defactinib in KRAS-mutant tumors.

x